VA Medicaid PDL Criteria (effective 01/01/2010)
... 1) The preferred product may be approved for patients if one of the following is true: a) If there has been a therapeutic trial and failure on a minimum of two (2) different non-COX2 NSAIDs (information on history can be determined from one of the options below) i) Electronic look back for history o ...
... 1) The preferred product may be approved for patients if one of the following is true: a) If there has been a therapeutic trial and failure on a minimum of two (2) different non-COX2 NSAIDs (information on history can be determined from one of the options below) i) Electronic look back for history o ...
CHITOSAN LOADED MICROSPHERES AS AN OCULAR DELIVERY SYSTEM FOR ACYCLOVIR S.SELVARAJ
... liposomes or nanoparticles7,8. Previous studies showed that both poly (alkylcyanoacrylate)9,10 and poly-ε-caprolactone 11,12,13 colloidal systems are able to improve the intraocular penetration of drugs. However, the duration of these systems at the ocular surface is limited to a few hours. In contr ...
... liposomes or nanoparticles7,8. Previous studies showed that both poly (alkylcyanoacrylate)9,10 and poly-ε-caprolactone 11,12,13 colloidal systems are able to improve the intraocular penetration of drugs. However, the duration of these systems at the ocular surface is limited to a few hours. In contr ...
Prescribing Information
... There are no adequate and well-controlled studies of modafinil in pregnant women. Intrauterine growth restriction and spontaneous abortion have been reported in association with modafinil (a mixture of R- and S-modafinil) and armodafinil (the R-enantiomer of modafinil). Although the pharmacology of ...
... There are no adequate and well-controlled studies of modafinil in pregnant women. Intrauterine growth restriction and spontaneous abortion have been reported in association with modafinil (a mixture of R- and S-modafinil) and armodafinil (the R-enantiomer of modafinil). Although the pharmacology of ...
NovoRapid® - Product Monograph Page 1 of 50 PRODUCT
... NovoRapid group and were not different from the human insulin group. No adverse effects could be attributed to patients producing cross-reactive antibodies as compared to those who did not. There was no correlation between the extent of antibody formation and the insulin dose needed, level of glycem ...
... NovoRapid group and were not different from the human insulin group. No adverse effects could be attributed to patients producing cross-reactive antibodies as compared to those who did not. There was no correlation between the extent of antibody formation and the insulin dose needed, level of glycem ...
Venous Relaxation Caused by Acetylcholine Acting on the
... Experiments were performed to determine whether acetylcholine affects the sympathetic activation of the cutaneous veins of the dog. Changes in isometric tension of saphenous vein strips were recorded at 37°C in an organ bath. Addition of acetylcholine at 1CH1 to 10~8 g/ml did not affect basal tensio ...
... Experiments were performed to determine whether acetylcholine affects the sympathetic activation of the cutaneous veins of the dog. Changes in isometric tension of saphenous vein strips were recorded at 37°C in an organ bath. Addition of acetylcholine at 1CH1 to 10~8 g/ml did not affect basal tensio ...
Briefing Document Treatment of Pneumonic Plague: Medical Utility of Ciprofloxacin
... zoonotic diseases affecting rodents, pigs, birds, and other domestic and wild animals; humans are only incidental hosts. However, pandemics due to Y. pestis have been responsible for large losses of human life and profound changes in society over the past two millennia (Dennis, 2009). Plague can hav ...
... zoonotic diseases affecting rodents, pigs, birds, and other domestic and wild animals; humans are only incidental hosts. However, pandemics due to Y. pestis have been responsible for large losses of human life and profound changes in society over the past two millennia (Dennis, 2009). Plague can hav ...
SDZ HTF 919 Stimulates Canine Colonic Motility and Transit In Vivo
... analysis of the colonic manometric tracings, two types of phasic pressure activities were analyzed, 1) all phasic contractile activity that had a frequency of .1 contraction/min and 2) contractions of .30-sec duration (i.e., up to 0.5 contraction/min). The average amplitude of contraction and the mo ...
... analysis of the colonic manometric tracings, two types of phasic pressure activities were analyzed, 1) all phasic contractile activity that had a frequency of .1 contraction/min and 2) contractions of .30-sec duration (i.e., up to 0.5 contraction/min). The average amplitude of contraction and the mo ...
T-61 Use in the Euthanasia of Domestic Animals: A Survey
... death swiftly and without pain or distress to animals, then veterinarians would be consistent in their recognition and acceptance of T-61 as a humane compound for euthanasia. But the truth is that there is no unanimous consensus in the veterinary profession to this end as evidenced by Andrew Rowan's ...
... death swiftly and without pain or distress to animals, then veterinarians would be consistent in their recognition and acceptance of T-61 as a humane compound for euthanasia. But the truth is that there is no unanimous consensus in the veterinary profession to this end as evidenced by Andrew Rowan's ...
4 Aqueous Extract of Human Placenta as a Therapeutic Agent Piyali Datta Chakraborty
... microbial (antibacterial or antifungal) properties but the potency of the extract lies in the fact that it not only reduces the inflammatory phase and microbial burden on the wound (Chakraborty and Bhattacharyya 2005b) but also help in cell migration (Gupta and Chottopadhyay, 2008), matrix formation ...
... microbial (antibacterial or antifungal) properties but the potency of the extract lies in the fact that it not only reduces the inflammatory phase and microbial burden on the wound (Chakraborty and Bhattacharyya 2005b) but also help in cell migration (Gupta and Chottopadhyay, 2008), matrix formation ...
Aminobutyric Acid (GABA) - Journal of Pharmacology and
... Food Experiments. Animals (n 5 6) on the FR5 schedule received a sweetened food pellet after every fifth response, followed by a 20-s time-out signaled as described above for the self-administration experiments. Sessions lasted 1 h. Once the rats had received all doses of GVG tested, four were advan ...
... Food Experiments. Animals (n 5 6) on the FR5 schedule received a sweetened food pellet after every fifth response, followed by a 20-s time-out signaled as described above for the self-administration experiments. Sessions lasted 1 h. Once the rats had received all doses of GVG tested, four were advan ...
PACIFIC BUSPIRONE Presentation NEW ZEALAND DATA SHEET
... with the stress of everyday life usually does not require treatment with an anxiolytic agent. Controlled clinical studies of buspirone have been limited to six months. ...
... with the stress of everyday life usually does not require treatment with an anxiolytic agent. Controlled clinical studies of buspirone have been limited to six months. ...
Abilify Maintena
... treatment, which patients are likely to develop the syndrome. Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown. The risk of developing tardive dyskinesia and the likelihood that it will become irreversible increase as the duration of treatment and ...
... treatment, which patients are likely to develop the syndrome. Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown. The risk of developing tardive dyskinesia and the likelihood that it will become irreversible increase as the duration of treatment and ...
150-514-1-SP - Baqiyatallah University of Medical Sciences
... protection in deep hypothermic circulatory arrest. The animals were randomly divided into two groups that underwent a 60-minute DHCA. The animals treated with dose of 500 U/kg EPO during three consecutive days which started of 24 hours before surgery to 24 hours after it. Intracerebral monitoring wa ...
... protection in deep hypothermic circulatory arrest. The animals were randomly divided into two groups that underwent a 60-minute DHCA. The animals treated with dose of 500 U/kg EPO during three consecutive days which started of 24 hours before surgery to 24 hours after it. Intracerebral monitoring wa ...
2013 Accomplishments
... statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, prospects, plans and objectives of management, are forwardlooking statements. The words ‘‘anticipate,’’ ‘‘believe,’’ ‘‘estimate,’’ ‘‘expect,’’ ‘‘inte ...
... statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, prospects, plans and objectives of management, are forwardlooking statements. The words ‘‘anticipate,’’ ‘‘believe,’’ ‘‘estimate,’’ ‘‘expect,’’ ‘‘inte ...
Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A
... extent of severity and clinical relevance. Not only co-medication, but also food and herbal medicine can interact with antimicrobial drugs and vice versa. The nature of these interactions can be of pharmacodynamic (PD) and/or pharmacokinetic (PK) origin. A PD interaction consists of an alteration of ...
... extent of severity and clinical relevance. Not only co-medication, but also food and herbal medicine can interact with antimicrobial drugs and vice versa. The nature of these interactions can be of pharmacodynamic (PD) and/or pharmacokinetic (PK) origin. A PD interaction consists of an alteration of ...
Evaluation of 22 SIN List 2.0 substances according to
... to be a secondary non-specific consequence of other toxic effects. However, when there is e.g. mechanistic information that raises doubt about the relevance of the adverse effect for humans or the environment, category 2a may be more appropriate. Substances can be allocated to this category based on ...
... to be a secondary non-specific consequence of other toxic effects. However, when there is e.g. mechanistic information that raises doubt about the relevance of the adverse effect for humans or the environment, category 2a may be more appropriate. Substances can be allocated to this category based on ...
Evaluation of 22 SIN List 2.0 substances according to the Danish
... effects at 10 mg/kg bw/day and below (STOT-RE Cat 1) lead to a classification as an endocrine disrupter of very high regulatory concern. Thus, the overall LOAEL for each substance was assessed, if possible, and evaluated in relation to this cut-off level of 10 mg/kg/day. In some cases, there was eff ...
... effects at 10 mg/kg bw/day and below (STOT-RE Cat 1) lead to a classification as an endocrine disrupter of very high regulatory concern. Thus, the overall LOAEL for each substance was assessed, if possible, and evaluated in relation to this cut-off level of 10 mg/kg/day. In some cases, there was eff ...
Sovaldi - Gilead
... with SOVALDI. Warnings and Precautions related to these drugs also apply to their use in SOVALDI combination treatment. ...
... with SOVALDI. Warnings and Precautions related to these drugs also apply to their use in SOVALDI combination treatment. ...
NUSRAT ADUSEI HAMENOO - Kwame Nkrumah University of
... behavioural effects on mice were observed in the study. The LD 50 of the aqueous extract was found to exceed 5000 mg/kg body weight. Sub-acute toxicity studies on the extract also showed no significant physical, physiological and behavioural effects. Haematological and biochemical studies also revea ...
... behavioural effects on mice were observed in the study. The LD 50 of the aqueous extract was found to exceed 5000 mg/kg body weight. Sub-acute toxicity studies on the extract also showed no significant physical, physiological and behavioural effects. Haematological and biochemical studies also revea ...
product monograph - Sobi North America
... changes. These findings were not associated with adverse clinical consequences. In all placebo-controlled studies 8% of patients receiving KINERET® had decreases in ANC of at least 1 World Health Organization toxicity grade, compared with 2% of placebo patients. Nine KINERET®-treated patients (0.4%) ...
... changes. These findings were not associated with adverse clinical consequences. In all placebo-controlled studies 8% of patients receiving KINERET® had decreases in ANC of at least 1 World Health Organization toxicity grade, compared with 2% of placebo patients. Nine KINERET®-treated patients (0.4%) ...
CMS Manual System Pub 100-04 Medicare Claims Processing
... A. Background: This instruction includes several revisions and clarifications regarding the instructions published for the ESRD Prospective Payment System and the ESRD Quality Incentive Program. Clarification of the Onset of Dialysis Adjustment for ESRD Claims The 2011 final rule for the End Stage R ...
... A. Background: This instruction includes several revisions and clarifications regarding the instructions published for the ESRD Prospective Payment System and the ESRD Quality Incentive Program. Clarification of the Onset of Dialysis Adjustment for ESRD Claims The 2011 final rule for the End Stage R ...
STALEVO (carbidopa, levodopa and entacapone)
... unable to control these urges while taking one or more of the medications generally used for the treatment of Parkinson’s disease and which increase central dopaminergic tone, including entacapone taken with levodopa and carbidopa. In some cases, although not all, these urges were reported to have s ...
... unable to control these urges while taking one or more of the medications generally used for the treatment of Parkinson’s disease and which increase central dopaminergic tone, including entacapone taken with levodopa and carbidopa. In some cases, although not all, these urges were reported to have s ...
PRODUCT MONOGRAPH
... Adverse events have been recorded during controlled clinical investigations in over 13,000 patients exposed to pantoprazole sodium as the single therapeutic agent for treatment of conditions requiring acid suppression. The following adverse reactions considered possibly, probably, or definitely rela ...
... Adverse events have been recorded during controlled clinical investigations in over 13,000 patients exposed to pantoprazole sodium as the single therapeutic agent for treatment of conditions requiring acid suppression. The following adverse reactions considered possibly, probably, or definitely rela ...
Assessment Report For Sprycel
... In the main study CA180056, the selected dose of dasatinib was 100 mg QD. Activity at this dose level was first documented in the Phase 1 study CA180002 (submitted in the initial marketing authorisation application). In a Phase 2 study in chronic phase CML subjects (CA180013, submitted in the initia ...
... In the main study CA180056, the selected dose of dasatinib was 100 mg QD. Activity at this dose level was first documented in the Phase 1 study CA180002 (submitted in the initial marketing authorisation application). In a Phase 2 study in chronic phase CML subjects (CA180013, submitted in the initia ...
drug interactions with calcium channel blockers: possible
... Ring, 1994; Sutton et al., 1997; Zhao and Ishizaki, 1997). With the exception of nifedipine, the inhibition effects of all CCBs were increased (from 2-fold for nicardipine to ⬎10-fold for verapamil and diltiazem) when preincubated in the presence of NADPH, similar to the observation with mibefradil ...
... Ring, 1994; Sutton et al., 1997; Zhao and Ishizaki, 1997). With the exception of nifedipine, the inhibition effects of all CCBs were increased (from 2-fold for nicardipine to ⬎10-fold for verapamil and diltiazem) when preincubated in the presence of NADPH, similar to the observation with mibefradil ...